Comparison of Dienogest and Continuous Combined Oral Contraceptive Pills Effects on Pain, Quality of Life, and Endometrioma Recurrence after Surgery for Endometriosis: A randomized Controlled Trial

Maryam Hashemi
2021 · doi:10.17632/f5pw9dj77h · W6963037056
RCT OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-21 ⓘ

This randomized trial compared dienogest and combined oral contraceptive pills in women with endometriosis after surgery, finding both treatments significantly reduced pelvic pain and improved quality of life without significant differences between groups.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-27 · read from full text ⓘ

This randomized controlled trial compared the efficacy of dienogest versus continuous combined oral contraceptive pills in managing pain, quality of life, and endometrioma recurrence following laparoscopic surgery for endometriosis. The study enrolled eighty women who received either medication daily for six months post-operation, assessing outcomes through self-reported measures of pelvic pain and sexual function. Results indicated that both treatments significantly improved overall pelvic pain scores and quality of life, with no statistically significant differences observed between the two groups regarding symptom relief or endometrioma recurrence rates. This paper is centrally about endometriosis — specifically evaluating postoperative medical management strategies to reduce pain and prevent disease recurrence after surgical intervention.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Study objective: To compare the effects of dienogest and combined oral contraceptive (COC) pills after laparoscopic conservative surgery on pain, quality of life (QOL), and recurrence of endometrioma in women with endometriosis. Design: Prospective randomized clinical trial study. Setting: Academic tertiary referral center. Methods: This study was conducted from April 2016 to June 2018 in women with endometriosis confirmed by surgery. Eighty patients who had undergone operative laparoscopy received dienogest or COC pills daily for six months. Results: Treatment with dienogest was associated with improved self-reported of all types of pelvic pain and quality of life after 6 months of treatment (P < 0.05). Improvement of these parameters was also observed in COC groups (P < 0.05), except for dyspareunia (p=0.089). Both of these pills significantly improved the scores of QOL and sexual function, but no remarkable differences were detected between the two groups in this regard (P < 0.05). About recurrence of endometrioma, there were no differences between dienogest and COC users (p=0.1). Conclusion: Postoperative administration of dienogest or COC pills after operative laparoscopy reduced pain and improved QOL in women with endometriosis. So, the choice of regimen can be adjusted according to the patientʼs symptoms, needs, and preferences. Keywords: Dienogest; Combined Oral Contraceptive; Endometriosis; Surgery; Pelvic Pain; Quality of Life
Full text 1,739 characters · extracted from oa-html · click to expand
Comparison of Dienogest and Continuous Combined Oral Contraceptive Pills Effects on Pain, Quality of Life, and Endometrioma Recurrence after Surgery for Endometriosis: A randomized Controlled Trial Description Abstract Study objective: To compare the effects of dienogest and combined oral contraceptive (COC) pills after laparoscopic conservative surgery on pain, quality of life (QOL), and recurrence of endometrioma in women with endometriosis. Design: Prospective randomized clinical trial study. Setting: Academic tertiary referral center. Methods: This study was conducted from April 2016 to June 2018 in women with endometriosis confirmed by surgery. Eighty patients who had undergone operative laparoscopy received dienogest or COC pills daily for six months. Results: Treatment with dienogest was associated with improved self-reported of all types of pelvic pain and quality of life after 6 months of treatment (P < 0.05). Improvement of these parameters was also observed in COC groups (P < 0.05), except for dyspareunia (p=0.089). Both of these pills significantly improved the scores of QOL and sexual function, but no remarkable differences were detected between the two groups in this regard (P < 0.05). About recurrence of endometrioma, there were no differences between dienogest and COC users (p=0.1). Conclusion: Postoperative administration of dienogest or COC pills after operative laparoscopy reduced pain and improved QOL in women with endometriosis. So, the choice of regimen can be adjusted according to the patientʼs symptoms, needs, and preferences. Keywords: Dienogest; Combined Oral Contraceptive; Endometriosis; Surgery; Pelvic Pain; Quality of Life Files Institutions - Isfahan University of Medical Sciences

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisendometriomadyspareunia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:53:50.615420+00:00
License: CC0 · commercial use OK